Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8(+) T cells.
- DOI
- 10.1016/j.omtn.2026.103076
- Published
- 2026 Dec 8
- Container
- Molecular therapy. Nucleic acids
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omtn.2026.103076,
title = {Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8(+) T cells.},
author = {Gold MJ and Millar DG and Liu J and Menon H and Karpov Y and Olsen K and Oliveira LT and Dubé C and Tran CW and Elford AR and Schwartz JA and Gopalakrishna Panicker RK and Marcusson EG and Ohashi PS and Martin Orozco N},
year = {2026},
journal = {Molecular therapy. Nucleic acids},
doi = {10.1016/j.omtn.2026.103076},
url = {https://doi.org/10.1016/j.omtn.2026.103076}
}RIS
TY - JOUR TI - Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8(+) T cells. AU - Gold MJ AU - Millar DG AU - Liu J AU - Menon H AU - Karpov Y AU - Olsen K AU - Oliveira LT AU - Dubé C AU - Tran CW AU - Elford AR AU - Schwartz JA AU - Gopalakrishna Panicker RK AU - Marcusson EG AU - Ohashi PS AU - Martin Orozco N PY - 2026 JO - Molecular therapy. Nucleic acids DO - 10.1016/j.omtn.2026.103076 UR - https://doi.org/10.1016/j.omtn.2026.103076 ER -
APA
MJ, G., DG, M., J, L., H, M., Y, K., K, O., LT, O., C, D., CW, T., AR, E., JA, S., RK, G. P., EG, M., PS, O., & N, M. O. (2026). Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8(+) T cells.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2026.103076
Source records
- pubmed · retrieved 2026-09-25T17:25:08.414Z